Anebulo Pharmaceuticals (ANEB) SEC Filings & 10K Form → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free ANEB Stock Alerts $2.79 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Recent Anebulo Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/08/20247:07 AMAnebulo Pharmaceuticals (Issuer)Cundy Kenneth C (Reporting)Form 4/A03/01/20245:24 PMAnebulo Pharmaceuticals (Issuer)Cundy Kenneth C (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/20/20233:22 PM22NW Fund, LP (Reporting)22NW, LP (Reporting)Anebulo Pharmaceuticals (Issuer)English Aron R. (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/14/20233:30 PMAnebulo Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/30/20238:22 AMAnebulo Pharmaceuticals (Filer)Form DEF 14A10/30/20238:31 AMAnebulo Pharmaceuticals (Filer)Form ARS10/19/20234:18 PMAnebulo Pharmaceuticals (Filer)Form PRE 14A10/11/20234:23 PMAnebulo Pharmaceuticals (Issuer)Cunningham, Richard Anthony (Reporting)Form 3Initial statement of beneficial ownership of securities 10/11/20234:25 PMAnebulo Pharmaceuticals (Issuer)Cunningham, Richard Anthony (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/10/20238:46 PMAnebulo Pharmaceuticals (Issuer)SHAH BIMAL R. (Reporting)Form 3Initial statement of beneficial ownership of securities 10/10/20238:49 PMAnebulo Pharmaceuticals (Issuer)SHAH BIMAL R. (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/06/20233:10 PMAnebulo Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/02/20234:01 PMAnebulo Pharmaceuticals (Issuer)George Dan (Reporting)Form 3Initial statement of beneficial ownership of securities 09/20/20233:15 PMAnebulo Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/05/20237:00 AMAnebulo Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/11/20237:15 AMAnebulo Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: LABP 10K Form DERM 10K Form CARM 10K Form VHAQ 10K Form ASMB 10K Form CUE 10K Form RLYB 10K Form VTVT 10K Form MNOV 10K Form CRVS 10K Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ANEB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
